- Home
- The People’s Voice
Arista’s founder agrees to $1M SEC penalty
In a stunning turn of events, Andreas “Andy” Bechtolsheim, the billionaire founder of Arista Networks Inc., has agreed to pay a hefty fine of nearly $1 million to settle allegations…
By Rihem AkkoucheLatest news
Vet Home Leader Resolves Landmark COVID-19 Case
In a groundbreaking development, the former leader of a Massachusetts veterans facility, embroiled in the first pandemic-related criminal…
By Rihem AkkoucheEnbridge $350M Into Natural Gas Joint Venture
Enbridge Inc., along with WhiteWater/I Squared Capital and MPLX LP, unveiled plans on Tuesday to forge a formidable…
By Rihem AkkoucheAthena Health Seek OK For Meal Break Wage Deal
Athena Health Care Systems, alongside two former employees, is seeking approval from a Connecticut federal court for a…
By Rihem AkkoucheUS EV Subsidies Face Allegations of Discrimination
In a bold move that could escalate tensions between economic giants, the Chinese Ministry of Commerce has accused…
By Rihem AkkoucheCarrefour Buying €365M Of Its Shares From Store Owner
In a strategic maneuver set to reshape its share landscape, hypermarket behemoth Carrefour announced Tuesday its plan to…
By Rihem AkkoucheKuCoin and Founders Face US Prosecution
Manhattan federal prosecutors have dropped a legal bombshell, unveiling an indictment charging foreign cryptocurrency exchange KuCoin and its…
By Rihem AkkoucheKen Paxton reaches deal to end securities fraud charges
In a dramatic turn of events, Texas Attorney General Ken Paxton has reached an agreement with state prosecutors…
By Rihem AkkoucheAppeals court sides with Donald Trump Jr in defamation suit
In a resounding decision, a Fourth Circuit panel has upheld Donald Trump Jr.‘s triumph in a defamation suit…
By Rihem AkkoucheControversial Social Media Platform Parler Makes a Comeback
Parler, the once-controversial social media platform, is back in the spotlight under new ownership. It’s relaunching now that…
By Jackie AllenAbbVie to buy Landos Biopharma for $212M
In a strategic move that sent shockwaves through the biopharmaceutical industry, AbbVie Inc. announced on Monday its intention…
By Rihem Akkouche
